News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,270 Results
Type
Article (2438)
Company Profile (39)
Press Release (35793)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14133)
Career Advice (77)
Deals (2080)
Drug Delivery (9)
Drug Development (4100)
Employer Resources (10)
FDA (435)
Job Trends (763)
News (20155)
Policy (1053)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (144)
Allergies (6)
Alliances (3479)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (15)
Approvals (436)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (13)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (20)
Cancer (143)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (44)
Cervical cancer (2)
Clinical research (3180)
Collaboration (94)
Compensation (48)
COVID-19 (180)
CRISPR (7)
C-suite (30)
Cystic fibrosis (2)
Data (114)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (464)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4242)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6040)
Executive appointments (96)
FDA (482)
Featured Employer (3)
Funding (79)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (149)
Healthcare (704)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (989)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (37)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (4)
Management (4)
Manufacturing (19)
MASH (4)
Medical device (308)
Medtech (308)
Mergers & acquisitions (1160)
Metabolic disorders (34)
Multiple sclerosis (8)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (92)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (366)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (5)
Peanut (1)
People (5667)
Pharmaceutical (5)
Phase I (1374)
Phase II (1595)
Phase III (846)
Pipeline (76)
Policy (12)
Postmarket research (30)
Preclinical (593)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (22)
Real estate (420)
Recruiting (5)
Regulatory (805)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (359)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (490)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1755)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (14)
Last 7 days (47)
Last 30 days (228)
Last 365 days (2540)
2025 (786)
2024 (2612)
2023 (2860)
2022 (3751)
2021 (4048)
2020 (3474)
2019 (2061)
2018 (1554)
2017 (1796)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1189)
2012 (1398)
2011 (1336)
2010 (1185)
Location
Africa (43)
Alabama (1)
Arizona (15)
Asia (1866)
Australia (298)
California (845)
Canada (134)
China (38)
Colorado (20)
Connecticut (10)
Delaware (4)
Europe (3848)
Florida (44)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (33)
Japan (7)
Kansas (12)
Maryland (25)
Massachusetts (305)
Michigan (8)
Minnesota (15)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (69)
New York (49)
North Carolina (90)
Northern California (366)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (50)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (359)
Tennessee (2)
Texas (72)
Utah (2)
Virginia (6)
Washington D.C. (2)
Washington State (52)
Wisconsin (6)
38,270 Results for "artelo biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results
March 3, 2025
·
7 min read
Press Releases
Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025
April 1, 2025
·
4 min read
Press Releases
Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland
February 11, 2025
·
4 min read
Press Releases
Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12
January 14, 2025
·
5 min read
Drug Development
Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium
Artelo Biosciences, Inc. today announced Professor Saoirse O’Sullivan, Vice President of Translational Sciences at Artelo, presented preclinical data related to ART26.12.
July 1, 2024
·
5 min read
Business
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
Artelo Biosciences, Inc. today reported financial and operating results for the three months ended March 31, 2024 and provided a business update.
May 13, 2024
·
7 min read
Biotech Beach
Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
Artelo Biosciences, Inc. today announced that it will be participating in the 2024 Pharma Partnering Summit being held May 14th – 15th in San Diego, California.
May 10, 2024
·
3 min read
Biotech Beach
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Artelo Biosciences, Inc. today announced its selection as a finalist in Johnson & Johnson’s Innovation Challenge.
March 12, 2024
·
4 min read
Biotech Beach
Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
Artelo Biosciences, Inc. today announced that Gregory D. Gorgas, President and Chief Executive Officer of Artelo, will be a featured guest on the Benzinga All Access show.
April 22, 2024
·
3 min read
Press Releases
Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia
December 10, 2024
·
6 min read
1 of 3,827
Next
